Day: March 30, 2026

us corporate news

Atmos Energy Corp 8-K SEC Filing Details for March 27, 2026 – Company Information, Address, and Security Data

Minichart

March 30, 2026

Atmos Energy Corporation Announces Extensions to Major Credi...

Continue Reading 0

us corporate news

Phio Pharmaceuticals Signs U.S. cGMP Manufacturing Agreement for PH-762 Drug Product Clinical Supply

Minichart

March 30, 2026

Phio Pharmaceuticals Corp. Announces cGMP Manufacturing Agre...

Continue Reading 0

us corporate news

Unicycive Therapeutics Reports 2025 Financial Results; OLC NDA Under FDA Review with Potential Approval in June 2026

Minichart

March 30, 2026

Unicycive Therapeutics Reports Full Year 2025 Financial Resu...

Continue Reading 0

us corporate news

Vine Hill Capital Investment Corp. Shareholders Approve Business Combination with CoinShares, Closing Expected March 31, 2026

Minichart

March 30, 2026

Vine Hill Capital Investment Corp. Shareholders Approve Busi...

Continue Reading 0

us corporate news

Terrestrial Energy Reports 2025 Results: $292M Raised, Texas A&M IMSR Plant Selected, DOE and NRC Milestones Achieved

Minichart

March 30, 2026

Terrestrial Energy Inc. Reports FY2025 Results: Major Milest...

Continue Reading 0

us corporate news

Sensei Biotherapeutics Acquires Faeth, Advances PIKTOR Cancer Program with $200M Financing and Reports 2025 Financial Results

Minichart

March 30, 2026

Sensei Biotherapeutics Reports Full Year 2025 Results, Annou...

Continue Reading 0

us corporate news

PROCAP Financial, Inc. Files Form 8-K Announcing Change in Certifying Accountant – March 2026

Minichart

March 30, 2026

ProCap Financial, Inc. Files Form 8-K: Key Shareholder Updat...

Continue Reading 0

us corporate news

Aquestive Therapeutics Completes FDA Type A Meeting for Anaphylm, Plans NDA Resubmission in Q3 2026

Minichart

March 30, 2026

Aquestive Therapeutics 8-K Report: Detailed Investor Update ...

Continue Reading 0

us corporate news

Bicara Therapeutics Inc. Files 8-K with SEC Detailing Q4 2025 Financials and Corporate Updates

Minichart

March 30, 2026

Bicara Therapeutics Inc. Reports Q4 and Full-Year 2025 Resul...

Continue Reading 0

us corporate news

Viridian Therapeutics Announces Positive Phase 3 Results for Elegrobart in Active Thyroid Eye Disease, Eyes 2027 FDA Submission

Minichart

March 30, 2026

Viridian Therapeutics Announces Positive Topline Results fro...

Continue Reading 0